uce
ProgressImage ProgressImage
Concord Drugs Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 538965 border-img ISIN Demat INE858L01010 border-img Book Value 35.40 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap ( Cr.) 37.19 border-img P/E 44.27 border-img EPS 0.84 border-img Face Value 10
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales12.627.388.79
Other Operating Income0.000.000.00
Other Income 0.000.010.00
Total Income12.627.398.79
Total Expenditure 12.065.857.39
PBIDT0.561.541.40
Interest 0.430.390.39
PBDT0.131.151.01
Depreciation0.380.380.38
Tax0.000.250.18
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.01-0.01-0.03
Reported Profit After Tax-0.240.530.49
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.240.530.49
    
EPS (Unit Curr.)-0.240.560.52
EPS (Adj) (Unit Curr.)-0.240.560.52
Calculated EPS (Unit Curr.)-0.240.560.52
Calculated EPS (Adj) (Unit Curr.)-0.240.560.52
Calculated EPS (Ann.) (Unit Curr.)-0.962.262.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.962.262.09
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.009.329.32
Reserve & Surplus24.1723.8322.88
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)4.4420.8715.93
PBDTM(%)1.0315.5811.49
PATM(%)-1.907.185.57
x
x
×
Let's Chat
close
refresh